Search Results for 'Egfr-Nsclc'

Egfr-Nsclc published presentations and documents on DocSlides.

EGFR-Mutated Advanced NSCLC

EGFR-Mutated Advanced NSCLC

by sherrill-nordquist

The Coming Paradigm Shift. Faculty. Suresh S. Ram...

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

by pasty-toler

This program will include a discussion of off-lab...

SW GLH services for NSCLC – An update

SW GLH services for NSCLC – An update

by everly

Professor Rachel Butler. The genomic complexity of...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

by chaptoe

proceedings from the live CME event and may includ...

by pasty-toler

MD. The Evolving Treatment Landscape in NSCLC: Co...

Using Non-targeted Therapies in Targeted Lung Cancer Popula

Using Non-targeted Therapies in Targeted Lung Cancer Popula

by ellena-manuel

Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...

by cheryl-pisano

Le Chevalier, . MD. The Role of Translational Res...

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

by sawyer742

Intervista a Federico . Cappuzzo. Background:. Pr...

Raising the Bar in the Management of Advanced/Metastatic NSCLC

Raising the Bar in the Management of Advanced/Metastatic NSCLC

by debby-jeon

Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...

Antiangiogenic Agents in Advanced NSCLC

Antiangiogenic Agents in Advanced NSCLC

by ellena-manuel

Jared Weiss, MD . Assistant . Professor of Medici...

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

by stefany-barnette

Renato G. Martins, MD, MPH. Medical Director, Tho...

Treatment in Advanced Non-Small Cell Lung Cancer

Treatment in Advanced Non-Small Cell Lung Cancer

by oconnor

. 5. th. most commonly diagnosed cancer in Austra...

Multidisciplinary approach to lung cancer

Multidisciplinary approach to lung cancer

by elena

Kamil Konopka. Department of Oncology, University ...

Beth Sandy, MSN, CRNP Nurse Practitioner

Beth Sandy, MSN, CRNP Nurse Practitioner

by PriceOfFreedom

Abramson Cancer Center . University of Pennsylvani...

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

by southan

Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pra...

Please note, these are the

Please note, these are the

by disclaimercanon

actual. . video-recorded proceedings from the . l...

The Role of Antiangiogenic Agents

The Role of Antiangiogenic Agents

by luanne-stotts

The Role of Antiangiogenic Agents in the Changin...

by alida-meadow

Gandara. , MD. University of California, Davis . ...

CLINICAL EXPERIENCE OF NSCLC in RSDM

CLINICAL EXPERIENCE OF NSCLC in RSDM

by sophia

Ana Rima. PENDAHULUAN. 2. Kanker Paru. P. enyebab ...

Jchem applications in Medchem

Jchem applications in Medchem

by StarsAndStripes

Prediction. . and. . Data Sorting. Zhengtao. Li...

Lung cancer Treatment

Lung cancer Treatment

by attentionallianz

Consequences of the Lack of Patients of color &...

L’algoritmo terapeutico

L’algoritmo terapeutico

by calandra-battersby

attraverso . i . c. asi clinici. Giuseppe . Valma...

Detection of Mutations in EGFR in Circulating Lung-Cancer C

Detection of Mutations in EGFR in Circulating Lung-Cancer C

by sherrill-nordquist

Colin Reisterer and Nick Swenson. S. . Maheswaran...

Targeting EGFR Exon 20 insertions

Targeting EGFR Exon 20 insertions

by unita

Gregory J. Riely. November 2021. What about those ...

Anti-EGFR induced skin

Anti-EGFR induced skin

by berey

toxicity. ESDO Learning Bytes 2021. Dr Violaine RA...

EGFR Mutation in Lung Adenocarcinoma (ADC)

EGFR Mutation in Lung Adenocarcinoma (ADC)

by QuietConfidence

Ana Rima. Lung Cancer: Incidence and Mortality. Ne...

Crystal digital PCR for detection and quantification of circulating EGFR mutations in advanced non-

Crystal digital PCR for detection and quantification of circulating EGFR mutations in advanced non-

by jasmine

Cécile Jovelet. Postdocoral. . fellow. Translati...

The EGFR Signaling Pathway

The EGFR Signaling Pathway

by cady

EGF. Epidermal Growth Factor (EGF). Binds to . Epi...

Best Practices in Nursing Management of EGFR Inhibitor Rash

Best Practices in Nursing Management of EGFR Inhibitor Rash

by olivia-moreira

Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pr...

Audit of EGFR mutation testing in patients with proven Non-

Audit of EGFR mutation testing in patients with proven Non-

by aaron

On behalf of the North of England Cancer Network ...

No Does the New EPOC trial eliminate anti-EGFR antibodies a

No Does the New EPOC trial eliminate anti-EGFR antibodies a

by sherrill-nordquist

The New EPOC Study. Randomi. ze. Surgery. Oxalipl...

CD3-EGFR Probody™ T Cell-engaging Bispecific Induces Tumo

CD3-EGFR Probody™ T Cell-engaging Bispecific Induces Tumo

by karlyn-bohler

Increases . Safety Window in Preclinical Studies....

Mechanisms of resistance to EGFR

Mechanisms of resistance to EGFR

by conchita-marotz

TKI. s. . and . related. . treatment . strategi...

Consensus or Controversy?

Consensus or Controversy?

by okelly

Addressing Practical Clinical Questions Across the...

NSCLC: Epidemiology and disease characteristics

NSCLC: Epidemiology and disease characteristics

by scarlett

NSCLC, non-small cell lung cancer.. Lung cancer in...

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

by stefany-barnette

The Cancer genome atlas (TCGA) and the search for...

by jane-oiler

of the expression of . 17-beta-hydroxysteroid . ...

NSCLC with high PD-L1 expression on tumor cells or tumor-in

NSCLC with high PD-L1 expression on tumor cells or tumor-in

by test

Intervista a Federico . Cappuzzo. Background:. P...

by luanne-stotts

Brada. . Torino. . 6 March 2015. Perspectives...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

by debby-jeon

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...